Tag: excellence
-
Novartis, Pfizer cut prices to win UK approval for cancer drugs
Novartis and Pfizer have won approval for two cancer drugs to be used routinely on Britain’s National Health Service after offering bigger price discounts. The National Institute for Health and Care Excellence (NICE) said on Thursday its draft guidance now recommended Novartis’ Afinitor for certain breast cancer patients and Pfizer’s Xalkori in lung cancer following…
-
UK okays Alexion drug costing up to 1.5 million pounds but wants price cut
A new drug to treat a rare inherited bone disorder that was developed by Alexion Pharmaceuticals and could cost up to 1.5 million pounds a year per patient has been cleared for limited use by Britain’s health cost watchdog. The National Institute for Health and Care Excellence (NICE), which had turned down Strensiq as too…
-
Roche breast cancer drug Perjeta rejected by NICE
Roche's breast cancer drug Perjeta, or pertuzumab, has been turned down for use on Britain's state health service, making it the latest in a number of pricey new cancer treatments deemed not to offer value for money. The National Institute for Health and Care Excellence (NICE) said in draft guidance on Friday that it could…
-
Yellow fever outbreaks in Africa need action, mass vaccination – WHO
By Stephanie Nebehay GENEVA (Reuters) – Outbreaks of deadly yellow fever in Angola and the Democratic Republic of Congo do not constitute a global health emergency but require stepped-up control measures and mass vaccination, the World Health Organisation (WHO) said on Thursday. “This can be a devastating disease with rapid spread particularly in urban areas,”…
-
What does the world know about rescued Chibok schoolgirl Amina Ali?
The rescue of one of more than 200 Nigerian schoolgirls abducted by the Islamist group Boko Haram from a secondary school in Chibok in northeastern Nigeria two years has thrown global attention onto Amina Ali. President Muhammadu Buhari vowed at a news conference on Thursday that Ali would continue her education and condemned the brutality…
-
UK agency backs cancer drug after Sanofi cuts price
LONDON (Reuters) – Britain's healthcare cost watchdog NICE said on Friday it had changed its mind and decided to recommend Sanofi's prostate cancer drug Jevtana after the French company agreed to a further discount. The National Institute for Health and Care Excellence (NICE) said the improved discount was “an excellent example of how pharma companies…
-
UK cost agency says ‘no’ to pricey Vertex cystic fibrosis drug
LONDON (Reuters) – A new cystic fibrosis treatment from Vertex Pharmaceuticals has been rejected as too expensive by Britain’s healthcare cost agency NICE. The National Institute for Health and Care Excellence (NICE) said on Wednesday that Orkambi, priced at an annual 104,000 pounds per patient, was not a cost-effective use of state healthcare resources, even…